Efficacy of Rivaroxaban versus Warfarin in Patients with Acute Left Ventricular Thrombus Following Myocardial Infarction: The RIVAWAR Trial

Efficacy of Rivaroxaban versus Warfarin in Patients with Acute Left Ventricular Thrombus Following Myocardial Infarction: The RIVAWAR Trial

The RIVAWAR Trial demonstrated that rivaroxaban was non-inferior to warfarin in resolving acute left ventricular (LV) thrombus three months after myocardial infarction (MI), according to a study presented by Dr. Jehangir Ali Shah, National Institute of Cardiovascular Diseases, Pakistan, in the Late-Breaking Clinical Trials session at ACC.25.

In the RIVAWAR trial, conducted between June 2021 and December 2023 at the National Institute of Car...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: The HOST-BR Trial
Dual Antiplatelet Therapy After PCI According To Bleeding Risk: The HOST-BR Trial
ACC.25
Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial
Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial
ACC.25
Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial
Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial
ACC.25
Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided PCI strategies: The FLAVOUR II Trial
Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided PCI strategies: The FLAVOUR II Trial
ACC.25
PICK UP
Challenging Healthcare Marketing Costs toward Achieving Universal Health Coverage
Special
InsighTCROSS
Outcomes of PCI for CTO in Dialysis Patients: Insights From the Japanese CTO-PCI Expert Registry
CCI
Outcomes of PCI for CTO in Dialysis Patients: Insights From the Japanese CTO-PCI Expert Registry
Association Between Stent-Edge Hinge Motion and Calcified Nodule Formation in Stent-Edge Calcified Coronary Lesions
Circ Intervention
Association Between Stent-Edge Hinge Motion and Calcified Nodule Formation in Stent-Edge Calcified Coronary Lesions
Aspirin-Free Strategy in High Bleeding Risk ACS and Non-ACS Patients Undergoing PCI: A Subgroup Analysis of the STOPDAPT-3 Trial
Circ Intervention
Aspirin-Free Strategy in High Bleeding Risk ACS and Non-ACS Patients Undergoing PCI: A Subgroup Analysis of the STOPDAPT-3 Trial
Digital Twin-Guided Patient Specific Rotor Ablation for Persistent Atrial Fibrillation: The CUVIA Trial
ESC 2025
Digital Twin-Guided Patient Specific Rotor Ablation for Persistent Atrial Fibrillation: The CUVIA Trial